Developing a method to quickly dehydrate vaccines and biopharmaceuticals at room temperature
Official title: Rapid Dehydration and Stabilization of Biopharmaceutical Formulations at Room Temperature
Funded at Inaedis, INC · NIH-10822843 · Data updated 2026-11-12
This study is working on a new way to dry vaccines and medicines quickly so they can be stored and shipped without needing to be kept cold, which could help more people get the treatments they need without worrying about them getting damaged.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Inaedis, INC NIH-funded |
| Lab location | 1 site (Princeton, United States) |
| Project start | December 27, 2023 |
| Project end | December 26, 2025 |
| Funding year | 2024 |
| Award (this year) | $312,634 |
| NIH project number | 1R41TR004571-01A1 |
| Project ID | NIH-10822843 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who require vaccinations or biopharmaceutical treatments that are currently affected by cold chain limitations.
✕Less likely to help
Patients who are not receiving vaccines or biopharmaceuticals that require cold storage may not benefit from this research.
What this research studies
This research focuses on creating a new technology that allows vaccines and biopharmaceutical formulations to be rapidly dehydrated using ultra-fine droplet aerosols, which can be stored and transported without the need for cold storage. By eliminating the cold chain requirement, this approach aims to reduce the loss of pharmaceuticals due to temperature-related damage, which currently affects a significant portion of the market. The methodology involves innovative drying techniques that are more efficient and less damaging than traditional methods, potentially improving vaccine access and effectiveness for patients.
Why it matters
Potential benefit: If successful, this research could lead to more reliable vaccine distribution and storage, ultimately improving patient access to effective immunizations.
How similar studies have gone: While there have been attempts to improve vaccine storage methods, this specific approach using ultra-fine droplet aerosols is novel and has not been extensively tested in prior research.
Where this research is happening
-
Inaedis, INC
Princeton, United States Active
Researchers
- Principal investigator: Mezhericher, Maksim — Inaedis, INC
- Study coordinator: Mezhericher, Maksim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.